DrugPatentWatch Database Preview
Insulin lispro recombinant - Biologic Drug Details
» See Plans and Pricing
Summary for insulin lispro recombinant
| Tradenames: | 4 |
| Patents: | 9 |
| Applicants: | 2 |
| BLAs: | 2 |
| Suppliers: see list | 4 |
| Recent Clinical Trials: | See clinical trials for insulin lispro recombinant |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for insulin lispro recombinant |
Recent Clinical Trials for insulin lispro recombinant
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Institut de Recherches Cliniques de Montreal | Phase 2 |
| Rigshospitalet, Denmark | Phase 4 |
| Beta Bionics, Inc. | Phase 2/Phase 3 |
Recent Litigation for insulin lispro recombinant
Identify key patents and potential future biosimilar entrants
District Court Litigation
| Case Name | Date |
|---|---|
| SANOFI-AVENTIS U.S. LLC v. MERCK SHARP & DOHME CORP. | 2017-08-08 |
Patent Text Search: US Patents for insulin lispro recombinant
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lilly | HUMALOG | insulin lispro recombinant | INJECTABLE;INJECTION | 020563 | 001 | 1997-01-09 | Start Trial | Aeropharm Technology Incorporated (Edison, NJ) | 2020-01-25 | DISCN | search | |
| Lilly | HUMALOG | insulin lispro recombinant | INJECTABLE;INJECTION | 020563 | 001 | 1997-01-09 | Start Trial | GP Medical, Inc. (Newport Beach, CA) National Tsing Hua University (Hsinchu, TW) | 2025-01-04 | DISCN | search | |
| Lilly | HUMALOG | insulin lispro recombinant | INJECTABLE;INJECTION | 020563 | 001 | 1997-01-09 | Start Trial | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (Gainesville, FL) | 2031-04-01 | DISCN | search | |
| Lilly | HUMALOG | insulin lispro recombinant | INJECTABLE;INJECTION | 020563 | 001 | 1997-01-09 | Start Trial | Corning Incorporated (Corning, NY) | 2031-10-25 | DISCN | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patents for insulin lispro recombinant
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011133198 | Start Trial |
| Japan | 6076962 | Start Trial |
| Brazil | PI0518093 | Start Trial |
| Australia | 2005322940 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for insulin lispro recombinant
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C0023 | France | Start Trial | PRODUCT NAME: INSULIN GLARGINE; NAT. REGISTRATION NO/DATE: EU/0/00/134/001 20000609; FIRST REGISTRATION: EU/1/00/134/001 20000609 |
| 213 | Luxembourg | Start Trial | PRODUCT NAME: INSULINE DEGLUDEC SOUS TOUTES LES FORMES PROTEGEES PAR LE BREVET DE BASE; AUTHORISATION NUMBER AND DATE: EU/1/12/807/001-4-5-7-8-9-12-13-15 TRESIBA 20130123 |
| 13C/035 | Belgium | Start Trial | PRODUCT NAME: TRESIBA-INSULINE DEGLUDEC; AUTHORISATION NUMBER AND DATE: EU/1/12/807/001 20130121 |
| C/GB05/024 | United Kingdom | Start Trial | PRODUCT NAME: INSULIN GLULISINE OR A PHYSIOLOGICALLY TOLERABLE SALT THEREOF; REGISTERED: UK EU/1/04/285/001 20040929; UK EU/1/04/285/002 20040929; UK EU/1/04/285/003 20040929; UK EU/1/04/285/004 20040929; UK EU/1/04/285/005 20040929; UK EU/1/04/285/006 20040929; UK EU/1/04/285/007 20040929; UK EU/1/04/285/008 20040929; UK EU/1/04/285/009 20040929; UK EU/1/04/285/010 20040929; UK EU/1/04/285/011 20040929; UK EU/1/04/285/012 20040929; UK EU/1/04/285/013 20040929; UK EU/1/04/285/014 20040929; UK EU/1/04/285/015 20040929; UK EU/1/04/285/016 20040929; UK EU/1/04/285/017 20040929; UK EU/1/04/285/018 20040929; UK EU/1/04/285/019 20040929; UK EU/1/04/285/020 20040929 |
| >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
